Mostra i principali dati dell'item

dc.contributor.authorLobe, Cindy
dc.contributor.authorVallette, Marie
dc.contributor.authorArbelaiz, Ander
dc.contributor.authorGonzález Sánchez, María Ester 
dc.contributor.authorIzquierdo, Laura
dc.contributor.authorPellat, Anna
dc.contributor.authorGuedj, Nathalie
dc.contributor.authorLouis, Corentin
dc.contributor.authorParadis, Valérie
dc.contributor.authorBanales, Jesus M
dc.contributor.authorCoulouarn, Cédric
dc.contributor.authorHousset, Chantal
dc.contributor.authorVaquero, Javier
dc.contributor.authorFouassier, Laura
dc.date.accessioned2026-02-09T10:15:44Z
dc.date.available2026-02-09T10:15:44Z
dc.date.issued2021
dc.identifier.citationLobe, C., Vallette, M., Arbelaiz, A., Gonzalez‐Sanchez, E., Izquierdo, L., Pellat, A., Guedj, N., Louis, C., Paradis, V., Banales, J., M, Coulouarn, C., Housset, C., Vaquero, J., Fouassier, L. (2021). Zinc Finger E‐Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling. Hepatology: 74(6):3194-3212.es_ES
dc.identifier.issn0270-9139
dc.identifier.urihttp://hdl.handle.net/10366/169637
dc.description.abstract[EN]BACKGROUND AND AIMS: Zinc finger E-box binding homeobox 1 (ZEB1) is a transcription factor that promotes metastatic and stem cell features, which has been associated with poor prognosis in cholangiocarcinoma (CCA), a desmoplastic cancer enriched in cancer-associated fibroblasts (CAFs). We aimed to define ZEB1 regulatory functions in malignant and stromal compartments of CCA. APP ROA CH AND RESULT S: Bioinformatic and immunohistochemical analyses were performed to determine correlations between ZEB1 and markers of progressiveness in human intrahepatic CCA (iCCA). Gain-of- function and loss-of- function models were generated in CCA cells and liver myofibroblasts as a model of CAFs. Conditioned media (CM) was used to unravel tumor–stroma interplay. In vivo experiments were performed using a xenograft CCA model. ZEB1 expression in tumor cells of human iCCA was associated with undifferentiated tumor and vascular invasion. In vitro, ZEB1 promoted epithelial–mesenchymal transition and stemness in tumor cells, leading to cell migration and spheroid formation. In vivo, ZEB1-overexpressing CCA cells formed larger tumors with more abundant stroma. Expression of cellular communication network factor 2 (CCN2, encoding connective tissue growth factor [CTGF]) was increased in tumor cells from ZEB1-overexpressing xenografts and correlated with ZEB1 expression in human tumors. In vitro, CM from ZEB1-overexpressing tumor cells or recombinant CTGF induced myofibroblast proliferation. ZEB1 was also expressed by CAFs in human CCA, and its expression correlated with CCN2 in myofibroblasts and CCA stroma. In mice, cotransplantation of CCA cells with ZEB1-depleted myofibroblasts reduced CCA progressiveness compared to CCA cells/ZEB1-expressing myofibroblasts. Furthermore, ZEB1 controls the expression of paracrine signals (i.e., HGF and IL6) in tumor cells and myofibroblasts. CONCLUSIONS: ZEB1 plays a key role in CCA progression by regulating tumor cell–CAF crosstalk, leading to tumor dedifferentiation and CAF activation.es_ES
dc.description.sponsorshipSupported by a fellowship from La Ligue Nationale contre le Cancer (13014, to C. Lobe); Inserm, Université de Rennes 1, INCa, and ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Santé) dans le cadre du Plan cancer (Noncoding RNA in Cancerology: Fundamental to Translational; C18007NS, to C.C.); a PhD fellowship from Université de Rennes 1 (to C. Louis); ANR (ANR-17- CE14- 0013- 01, to L.F.); the Fondation pour la Recherche Médicale (FRM SPF201809007054, to A.A.); and Les Entreprises contre le Cancer Paris–Île- de- France (GEFLUC; 2019, to A.A. and L.F.). J.V. received postdoctoral fellowships from the Spanish Association for the Study of the Liver, the Fondation ARC (PDF2014601431), and the LABEX Plas@par project as well as financial state aid managed by the Agence Nationale de la Recherche as part of the programme “Investissements d’avenir” (ANR-11-IDEX-0004-02); J.V. has been funded by the Ministerio de Ciencia e Innovación, which is part of Agencia Estatal de Investigación, through the Retos Investigación grant (RTI2018-094079 and PID2019-108651RJ- I00). J.M.B. is funded by the Spanish Carlos III Health Institute (FIS PI15/01132, PI18/01075, and the Miguel Servet Program CON14/00129; cofinanced by the Fondo Europeo de Desarrollo Regional, the Basque Foundation for Innovation and Health Research (EiTB Maratoia BIO15/CA/016/BD), and the Fundación Científica de la Asociación Española Contra el Cáncer. C.H. and L.F. are supported by the Fondation pour la RechercheMédicale (Equipe FRM 2020 n°EQU202003010517)es_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.publisherAASLD Publicationses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectzeb1es_ES
dc.subjectcholangiocarcinomaes_ES
dc.subjectTumor Microenvironmentes_ES
dc.subjectMyofibroblastses_ES
dc.subject.meshStromal Cells *
dc.subject.meshCholangiocarcinoma *
dc.subject.meshEpithelial-Mesenchymal Transition *
dc.subject.meshMyofibroblasts *
dc.subject.meshParacrine Communication *
dc.titleZinc Finger E‐Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signalinges_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1002/hep.32069es_ES
dc.subject.unesco3209 Farmacologíaes_ES
dc.subject.unesco2403 Bioquímicaes_ES
dc.identifier.doi10.1002/hep.32069
dc.relation.projectIDRTI2018-094079es_ES
dc.relation.projectIDPID2019-108651RJ- I00es_ES
dc.relation.projectIDFIS PI15/01132es_ES
dc.relation.projectIDPI18/01075es_ES
dc.relation.projectIDCON14/00129es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.identifier.pmid34297412
dc.identifier.essn1527-3350
dc.journal.titleHepatologyes_ES
dc.volume.number74es_ES
dc.issue.number6es_ES
dc.page.initial3194es_ES
dc.page.final3212es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decscélulas del estroma *
dc.subject.decsmiofibroblastos *
dc.subject.decstransición epiteliomesenquimatosa *
dc.subject.decscolangiocarcinoma *
dc.subject.decscomunicación paracrina *


Files in questo item

Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional